Inclusion of MUC1 (Ma695) in a panel of immunohistochemical markers is useful for distinguishing between endocervical and endometrial mucinous adenocarcinoma*

BACKGROUND: Distinguishing endocervical adenocarcinoma (ECA) from endometrial mucinous adenocarcinoma (EMMA) is clinically significant in view of the differences in their management and prognosis. In this study, we used a panel of tumor markers to determine their ability to distinguish between prima...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Khoury, Thaer, Tan, Dongfeng, Wang, Jianmin, Intengan, Marilyn, Yang, Jun, Alrawi, Sadir, Yan, Peisha, Byrd, James C
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2006
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1382242/
https://ncbi.nlm.nih.gov/pubmed/16409624
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6890-6-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados